Evaluation of CA15/3 serum levels in breast cancer patients.

MLA

Gion, M., et al. “Evaluation of CA15/3 Serum Levels in Breast Cancer Patients.” The Journal of Nuclear Medicine and Allied Sciences, vol. 30, no. 1, Jan. 1986, pp. 29–36. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=3462353&authtype=sso&custid=ns315887.

APA

Gion, M., Mione, R., Dittadi, R., Fasan, S., Pallini, A., & Bruscagnin, G. (1986). Evaluation of CA15/3 serum levels in breast cancer patients. The Journal of Nuclear Medicine and Allied Sciences, 30(1), 29–36.

Chicago

Gion, M, R Mione, R Dittadi, S Fasan, A Pallini, and G Bruscagnin. 1986. “Evaluation of CA15/3 Serum Levels in Breast Cancer Patients.” The Journal of Nuclear Medicine and Allied Sciences 30 (1): 29–36. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=3462353&authtype=sso&custid=ns315887.